This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.
In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.
In your application messsage, please share your background and what you can contribute to the group.
Company Overview and News
A proposal by seven local conglomerates to upgrade and operate Manila’s Manila’s Ninoy Aquino International Airport, the country’s busiest air gateway, is set to move forward.
JGSMY JGS MPCIY AEV FILIY ALGGY ABTZY MPI MPCFF ALGGF FDC AGI JGSHF
THE MANILA International Airport Authority (MIAA) has received a recommendation from the Department of Transportation (DoTr) to accept the unsolicited proposal of the consortium of seven conglomerates to rehabilitate the Ninoy Aquino International Airport (NAIA).
JGSMY JGS MPCIY GMQRY GMRINFRA 532754 FILIY ALGGY MWP MPI MPCFF ALGGF FDC AGI MWIDE JGSHF
TEN Philippine companies made it to the Nikkei Asian Review’s third annual list of Asia300 Power Performers Ranking, which ranks the most powerful and valuable listed companies in Asia.
JGSMY GTCAP GTCXY JGS CEBUY JBFCF MPCFF SPHXF SPHZF CEB JGSHF UVRBF AYAAF DMC MPCIY AYAAY JBFCY DMCIF UVRBY DMCP SMPH CEBUF MPI SPHXY JFC URC DMCHY ALI
Gokongwei-led Robinsons Bank has returned to the local debt market with an offering of as much as P5 billion worth of high-yielding deposits, proceeds from which will fund the bank’s aspiration to becoming one of the country’s leading banks.
JGSMY JGS RBNTF RRETY JGSHF RRHI
(June 26): Philippine shares closed higher for the first time in nine sessions on Tuesday, driven mainly by industrial and real estate stocks, while Indonesian shares fell for a fifth session in six.
SMPH JGSMY JGS SPHXY SPHXF SPHZF JGSHF
(June 19): Southeast Asian stock markets declined on Tuesday, with Thailand and Vietnam closing more than 2% lower, as escalating US-China trade tensions led to a broad sell-off in regional equities.
JGSMY DBSDY PBLOF SVTMF MLYBY JGS MLYNF BDOUY SM 1295 O39 BDOUF 1155 BDO D05 SMIVY DBSDF JGSHF
NEW YORK, June 18 — Southeast Asian stock markets fell today, in line with broader Asia as a trade spat intensified between the world’s top two economies.
UOVEF JGSMY ICT SMIVY SVTMF JGS UOVEY SM ICTEF JGSHF U11
SINGAPORE, June 13 — Most South-east Asian stock markets declined today, in line with broader Asia ahead of the US Federal Reserve's policy decision which could give cues on future rate hikes.
UOVEF JGSMY DBSDY PBLOF SVTMF JGS BDOUY SM 1295 U11 BDOUF BDO D05 SMIVY DBSDF UOVEY JGSHF
SINGAPORE, June 11 — South-east Asian stock markets trod water today ahead of a US-North Korea summit that could lay the groundwork for ending a nuclear stand-off between the old foes, while investors also started to focus on key central bank meetings later this week.
GMALY 1155 JGSMY SMIVY SVTMF MLYBY 4715 GMALF JGS MLYNF SM JGSHF
The benchmark Philippine Stock Exchange index (PSEi) closed lower yesterday as investors pocketed profits amid recent gains.
ICT JGSMY GTCAP GTCXY NOW JGS BDOUY ICTEF BDOUF PHSXY PSE SPHXF SPHZF JGSHF UVRBF AYAAF PSKXF AYAAY UVRBY SMPH BDO SPHXY URC DNOW ALI
JG SUMMIT Holdings, Inc. is hiking its capital spending for 2018 as it aims to grow its petrochemical, airline, property, food and beverage, and banking businesses amid higher oil prices in the world market and the further depreciation of the peso.
JGSMY JGS RBNTF CEBUY UVRBY RBLAY CEBUF RLC RRETY URC CEB JGSHF UVRBF RRHI
2018-07-17 - Asif
History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...
2018-07-17 - Asif
Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...
2018-07-16 - Asif
General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...